Biologicals in the prevention and treatment of intestinal graft rejection: The state of the art Biologicals in Intestinal Transplantation
-
Published:2024-07
Issue:4
Volume:85
Page:110810
-
ISSN:0198-8859
-
Container-title:Human Immunology
-
language:en
-
Short-container-title:Human Immunology
Author:
Karmi NaomiORCID,
Uniken Venema Werna T.C.,
van der Heide Frans,
Festen Eleonora A.M.,
Dijkstra Gerard
Reference40 articles.
1. R. Venick, International Intestinal Transplant Registry: 2023 Update, (2023).
2. Intestinal transplant immunology and intestinal graft rejection: from basic mechanisms to potential biomarkers;Rumbo;Int. J. Mol. Sci.,2023
3. Immunosuppressive drugs for kidney transplantation;Halloran;N. Engl. J. Med.,2004
4. S.S. Guimaraes Koch, R. Thorpe, N. Kawasaki, M.-P. Lefranc, S. Malan, A.C.R. Martin, G. Mignot, A. Plückthun, M. Rizzi, S. Shubat, K. Weisser, R. Balocco, International nonproprietary names for monoclonal antibodies: an evolving nomenclature system, mAbs 14 (2022) 2075078. DOI: 10.1080/19420862.2022.2075078.
5. Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar;Buurman;PLoS One,2018